| John Mark Simpson, RPH | |
|
1837 W 4700 S, Taylorsville, UT 84118-1103 | |
| (801) 967-0682 | |
| (801) 964-5773 |
| Full Name | John Mark Simpson |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 1837 W 4700 S, Taylorsville, Utah |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366735789 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 151232 (Utah) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| John Mark Simpson, RPH 1837 W 4700 S, Taylorsville, UT 84118-1103 Ph: (801) 967-0682 | John Mark Simpson, RPH 1837 W 4700 S, Taylorsville, UT 84118-1103 Ph: (801) 967-0682 |
News Archive
Comprehensive Pharmacy Services has been chosen as a preferred provider for pharmacy services by THA Solutions Group.
The antibiotic fidaxomicin (trade name: Dificlir) has been approved in Germany since December 2011 for the treatment of adults who have diarrhoea caused by Clostridium difficile.
Massachusetts health care officials this month are boosting efforts to enroll low-income residents in subsidized health insurance plans as the state approaches the Dec. 31 deadline for all residents to obtain coverage or face tax penalties, the Boston Globe reports.
New findings about the mechanisms involved - or not involved - in the effects of the most common form of bariatric surgery suggest that combining surgery with a specific type of medication could augment the benefits of the procedure. In a report that has been published online in the journal Endocrinology, Massachusetts General Hospital investigators report that the effects of Roux-en-Y gastric bypass (RYGB) do not utilize neurologic pathways controlled by the serotonin 2C receptor.
Researchers at Moffitt Cancer Center and colleagues have demonstrated that the inhibition of signal transducer and activator of transcription 3 (STAT3) in mouse models of mantle cell lymphoma (MCL), an aggressive and incurable subtype of B-cell non-Hodgkin lymphoma that becomes resistant to treatment, can harness the immune system to eradicate residual malignant cells responsible for disease relapse.
› Verified 5 days ago
Abdulrahman A Almalki, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4393 S Riverboat Rd, Taylorsville, UT 84123 Phone: 801-284-1078 | |
Phung Matthews, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1837 West 4700 South, Taylorsville, UT 84118 Phone: 801-967-0682 | |
Banou Rafiei, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1837 W 4700 S, Taylorsville, UT 84129 Phone: 801-967-0682 | |
Mr. Gail Cook Mcomber, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3835 W 5400 S, Taylorsville, UT 84118 Phone: 801-966-1488 | |
Mr. Phillip Thurber Tinkham, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3845 W 4700 S, Taylorsville, UT 84118 Phone: 801-840-4350 Fax: 801-840-4357 | |
Mrs. Tuyen Kailyn Truong, PHARMD. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4668 S Redwood Rd, Taylorsville, UT 84123 Phone: 801-967-4972 | |
Jeffery Dee Speth Jr., PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4393 S Riverboat Rd, Taylorsville, UT 84123 Phone: 801-284-1073 |